Last updated 2026-07-26
- Raised $27M Series D led by Sofinnova Partners, Mar 2020
- Raised $10M Series C led by Viventures, Dec 2015
- Raised Series E led by Minogue Consulting, Oct 2024
Total raised
$37.0M
Last: Undisclosed Round 2024-11
Stage
Series C
Founded
2009
Headcount
125
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
Pi-Cardia is a global leader in the development of a unique portfolio of non-implant, catheter-based, leaflet modification solutions for treating heart valves. The company's proprietary technology involves delivering mechanical impact to create fractures in valve calcifications without injuring surrounding soft tissue. This treatment aims to increase the valve's effective orifice area, potentially eliminating the need for valve replacement. Their products, ShortCut™ and Leaflex™, address conditions like aortic stenosis and facilitate valve-in-valve TAVR procedures.
Funding history · 5 rounds · $37.0M total
2024-10
E Round
Undisclosed
★ Minogue Consulting
2020-03
D Round
$27.0M
★ Sofinnova PartnersJacques SguinClal Biotechnology Industries (CBI)
2015-12
C Round
$10.0M
★ Viventures★ Innogest Capital★ Atlante Ventures★ Anatomy Medical Technology Fund★ Clal Biotechnology Industries (CBI)
2015-08
B Round
Undisclosed
★ Accelmed★ Clal Biotechnology Industries (CBI)
2011-11
A Round
Undisclosed
Headcount over time
From 10 (2018-08) to 74 (2026-03) · +64 (+640%) · 50 points · source: Finder history + radar grounding
Q&A
- What is Pi-Cardia's primary focus?
- Pi-Cardia is a medical device company developing non-implant, catheter-based solutions for treating heart valve calcification and aortic stenosis.
- When was Pi-Cardia founded?
- Pi-Cardia was founded in January 2009.
- How many employees does Pi-Cardia currently have?
- Pi-Cardia has 51–200 employees.
- Which company led Pi-Cardia's Series C funding round in April 2020?
- Sofinnova Partners led Pi-Cardia's Series C funding round in April 2020, which raised $27,000,000.
- What is Pi-Cardia's total amount raised to date?
- Pi-Cardia has raised a total of $74,100,000 USD.
- Which product from Pi-Cardia received FDA IDE approval for a pivotal study?
- Pi-Cardia received FDA IDE approval for a pivotal study with its ShortCut™ device in July 2022.
- When did Pi-Cardia successfully perform mitral valve splitting with its ShortCut™ product?
- Pi-Cardia successfully performed mitral valve splitting with its ShortCut™ product in August 2022.
Team · 2
Eyal Kolka
Founder · Co-Founder & Executive Director
Erez Golan
Founder · Co-Founder & CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
medical-devicescardiovascularsurgerycardiologycathetersvalvessurgeonsmedical-productstreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | pi-cardia.net |
|---|---|
| linkedin.com/company/5079787 |
Identifiers & details
| Former names | Pi R Squared |
|---|---|
| Founded | 2009-1 |
| Employees (exact) | 125 |
Radar intelligence
Patents
| EPO | 22 |
|---|
Web history (Wayback)
| Domain | pi-cardia.net |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514181379 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2008-09-02 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 7 — shares_capital (1), other (1), annual_report (3), charge (1), people (1) |
| Registered address | פייקס דוד 5 רחובות |
Recent registry events
| Date | Event |
|---|---|
| 2026-04-30 | הגדלה של הון רשום |
| 2026-04-30 | שינוי בתקנון |
| 2025-09-04 | דו~ח שנתי-הסרת בעל תפקיד |
| 2025-09-04 | דו~ח שנתי-הקצאת מניות |
| 2025-09-04 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2026-03-01 | עדכון שעבוד |
| 2026-02-01 | עדכון בעלי תפקידים |